Projects per year
Personal profile
Biography
Professor David Gillatt MB ChB FRCS FRCS(E) FRCS (Urol) FRACS ChM
Professor of Urological Oncology and Robotic Surgery, Macquarie University
Head of Urology Clinical Discipline, Macquarie University
Director of Medical and Surgical Services, MQ Health Pty Limited
Urology Consultant, Macquarie University Hospital Clinic and Hospital, The St George Hospital and St George Private Hospital
Professor David Gillatt is a leading prostate and bladder cancer surgeon with more than 25 years’ experience who currently holds the position of Director of Medical and Surgical Services and Professor of Urological Oncology and Robotics at MQ Health/Macquarie University Hospital, Sydney. Prof Gillatt is also recognised as one of world’s foremost robotic surgeon in the treatment of both prostate and bladder cancers having performed more than 2000 major resections in his career. He specialises in urology and nephrology and is well known for introducing the Enhance Recovery program for cystectomy, which was the first of its kind globally.
For the last 15 years he has concentrated on urological cancer surgery. As a result, he has one of the largest experiences of pelvic cancer surgery in the UK and Europe. In 2008 Professor Gillatt introduced a robotically assisted surgery program and has performed approximately 1000+ cases. He introduced and designed a systematic method of training for both established surgeons and trainees on the robot console.
Before joining Macquarie University Hospital, Professor Gillatt was Clinical Director of Urology at Southmead Hospital; and Medical Director of the Bristol Urological Institute, where he established the Prostate Cancer Care and Research Centre. The centre has gained a national reputation as one of the foremost research organisations for urology in the UK.
His research interests are both in clinical trials and basic science and for 16 years was the Bristol Chief investigator for the national Protect study. David has expertise in the discovery and optimisation of biomarkers for early prostate cancer diagnosis and prognosis, and in the effect of ketamine abuse on bladder function.
A key focus of David’s current role is strengthening the Macquarie University Hospital’s multidisciplinary team approach to prostate cancer care that already sees coordinated services engage all relevant specialities with the aim of delivering outstanding patient car. Professor Gillatt welcomes new patients in his room at Macquarie University Clinic.
Professor David Gillatt is recognised as one of world’s foremost robotic surgeon in the treatment of both prostate and bladder cancers having performed more than 2000 major resections in his career. He is also
He supports biomarker research in areas such as IGF’s and prostate cancer and volatiles and cancer diagnostics.
A leading prostate and bladder cancer surgeon with more than 25 years’ experience who currently holds the position of Director of Medical Services and Professor of Urological Oncology and Robotics at MQ Health/Macquarie University Hospital, Sydney. He specialises in urology and nephrology and is well known for introducing the Enhance Recovery program for cystectomy, which was the first of its kind globally.
Professor Gillatt has extensive experience in all areas of Urology. For the last 15 years he has concentrated on urological cancer surgery. As a result, he has one of the largest experiences of pelvic cancer surgery in the UK and Europe. In 2008 Professor Gillatt introduced a robotically assisted surgery program and has performed approximately 1000+ cases. He introduced and designed a systematic method of training for both established surgeons and trainees on the robot console.
His research interests are both in clinical trials and basic science and for 16 years was the Bristol Chief investigator for the national Protect study. He supports biomarker research in areas such as IGF’s and prostate cancer and volatiles and cancer diagnostics.
A key focus of David’s current role is strengthening the Macquarie University Hospital’s multidisciplinary team approach to prostate cancer care that already sees coordinated services engage all relevant specialities with the aim of delivering outstanding patient car. Professor Gillatt welcomes new patients in his room at Macquarie University Clinic.
Education/Academic qualification
Surgery, Fellow, Royal Australasian College of Surgeons
Award Date: 5 Nov 2015
Surgery, Fellow, Royal College of Surgeons of England
Award Date: 11 Feb 1993
Medicine, Surgeon, The Royal College of Surgeons of Edinburgh
Award Date: 6 Jul 1984
Medicine, Surgeon, University of Manchester
Award Date: 7 Jul 1980
Surgery, Fellow , Royal College of Surgeons of England
1985 → …
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
COMPyL: Evaluation of Prostate Specific Membrane Antigen expression in lesions diagnosed as Prostate Cancer using (2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid) (18F DCFPyL) PET/CT imaging in men undergoing Radical Prostatectomy
Gillatt, D., Chapman, N. & Rai, M.
31/03/20 → 1/02/25
Project: Research
-
A research assistant to build capacity in and use of Macquarie's bioreactor equipment: towards production and maintenance of live bioartificial tissues for sustainable scientific use
Sen, I., Avolio, A., Gillatt, D., Zvyagin, A., De Deene, Y., Vickery, K., Fuerbach, A. & Parker, L.
1/01/17 → …
Project: Research
-
A phase II randomised controlled trial of high dose Vitamin D in localised prostate cancer cases with intermediate risk of progression (Pros-D).
Gurney, H., Butala, R., Nair-Shalliker, V., Smith, D., Gebski, V., Patel, M., Frydenberg, M., Gardiner, R., Kimlin, M., Fenech, M. & Gillatt, D.
1/03/16 → …
Project: Research
-
CRC-P round 9: Manufacturing consortium for cancer radioimmunotherapy
Groth, A., Chandler, C., Adams, T., Walsh, B., Lengkeek, N., Chung, R., Gurney, H., Gillatt, D. & O'Meara, T.
1/07/20 → 30/06/23
Project: Research
-
Investigating the diagnostic utility of hyperspectral retinal imaging in preclinical Alzheimer's disease
Martins, R., Gillatt, D., Graham, S. L., Chatterjee, P., Goozee, K., Gupta, S., Shah, T. & Sohrabi, H.
1/12/17 → 13/10/20
Project: Research
-
Implementation of consensus-based perioperative care pathways to reduce clinical variation for elective surgery in an Australian private hospital: a mixed-methods pre–post study protocol
Pagano, L., Hemmert, C., Hirschhorn, A., Francis-Auton, E., Arnolda, G., Long, J. C., Braithwaite, J., Gumley, G., Hibbert, P. D., Churruca, K., Hutchinson, K., Partington, A., Hughes, C., Gillatt, D., Ellis, L. A., Testa, L., Patel, R. & Sarkies, M. N., 26 Jul 2023, In: BMJ Open. 13, 7, p. 1-8 8 p., e075008.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Novoglan device for treatment of adult phimosis: Novoglan-01 open-label clinical trial on safety, efficacy and tolerability
Chung, E., Polikarpov, D., Mazure, H., James, A., Doosti, H., Campbell, D. & Gillatt, D., Jul 2023, In: Translational Andrology and Urology. 12, 7, p. 1050-1061 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile13 Downloads (Pure) -
Detection of rare prostate cancer cells in human urine offers prospect of non-invasive diagnosis
Sayyadi, N., Justiniano, I., Wang, Y., Zheng, X., Zhang, W., Jiang, L., Polikarpov, D. M., Willows, R. D., Gillatt, D., Campbell, D., Walsh, B. J., Yuan, J., Lu, Y., Packer, N. H., Wang, Y. & Piper, J. A., Dec 2022, In: Scientific Reports. 12, 1, p. 1-9 9 p., 18452.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)9 Downloads (Pure) -
MiCheck prostate blood test for aggressive prostate cancer designed for the clinical lab setting
Shore, N. D., Pieczonka, C. M., Henderson, R. J., Bailen, J. L., Saltzstein, D. R., Concepcion, R. S., Gillatt, D., Chan, D. W., Campbell, D., Lu, Y., Le, T. H., Deng, N. & Basseal, D., 20 Feb 2022, In: Journal of Clinical Oncology. 40, 6 suppl, 1 p., 229.Research output: Contribution to journal › Meeting abstract
Open Access -
A biopsychosocial approach to characterising men with cognitive changes following hormone therapy for prostate cancer: a systematic scoping review
Pembroke, L., Dhillon, H. M., Francis, H., Gurney, H., Gillatt, D. & Sherman, K., Jun 2021, In: International Journal of Behavioral Medicine. 28, S1, p. S17 1 p.Research output: Contribution to journal › Meeting abstract